BioAffinity Technologies announced that J. Michael Edwards has accepted the position of CFO. Edwards has been BioAffinity’s interim CFO since September 15 and previously served as BioAffinity’s consulting CFO from 2014 to 2023, overseeing the Company’s initial public offering in 2022.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BIAF:
- bioAffinity Technologies Expands Access to Lung Cancer Test
- BioAffinity awarded U.S.federal supply schedule contract for CyPath Lung
- BioAffinity Technologies files to sell 1.8M shares of common stock for holders
- bioAffinity Technologies Announces CFO Transition and Appointment
- BioAffinity Technologies CFO Michael Dougherty resigns